MedTrace Logo

Fertility Preservation in Young Women With Cancer

NCT02878434 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2020-11-18

No results posted yet for this study

Summary

The researchers aim to record the incidence, treatment and long term follow up of fertility preserving cancer treatment. Both the oncological and fertility outcome are recorded.

Study population: All patients with a cancer for whom a fertility preserving cancer treatment is applied. The results of the study population are compared to young women undergoing standard cancer treatment.

Conditions

Sponsors & Collaborators

  • NKI-AvL

    collaborator UNKNOWN

  • Medical University of Vienna

    collaborator OTHER

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    collaborator OTHER

  • Oslo University Hospital

    collaborator OTHER

  • Haukeland University Hospital

    collaborator OTHER

  • N.N. Blokchin NMRCO

    collaborator UNKNOWN

  • University Hospital, Gasthuisberg

    lead OTHER

Principal Investigators

  • Frédéric Amant, MD, PhD · UZ Gasthuisberg & KU Leuven, Belgium

Eligibility

Min Age
0 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-23
Primary Completion
2032-07-31
Completion
2032-07-31

Countries

  • Belgium
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02878434 on ClinicalTrials.gov